Group 1 - KKR reported a 9% increase in adjusted net income for Q2, reaching $1.1 billion, or $1.18 per share, surpassing LSEG's estimate of $1.13 per share [1] - Fee-related income grew by 17% to $887 million, driven by management fees and capital markets business, despite high market volatility due to trade tariff promises from President Trump [2] - KKR's total assets under management reached $686 billion, a 14% year-over-year increase, with $28 billion in new capital raised during the quarter [3] Group 2 - KKR announced the acquisition of HealthCare Royalty Partners, focusing on royalty rights from pharmaceutical sales [3] - The company is collaborating with Capital Group to seek SEC approval for a fund that combines public markets and private equity, targeting the growing demand from affluent retail investors [3] - KKR raised $6.5 billion for an asset-backed financing fund, aiming to identify debt purchase opportunities similar to its deal with PIMCO for Harley-Davidson [3]
凯雷集团第二季度利润因手续费收入增长而上升